Recently, in a transgenic mouse model of PD exosome-mediated delivery of an antisense oligonucleotide (exo-ASO4) has been found to significantly decrease the expression of SYN, to attenuate its aggregation and ameliorate the degeneration of dopaminergic neurons [79]. Here, FYN is linked to Parkinson disease.